Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
A highly regarded firm known for its international reach and the breadth of its expertise in business deals. Experienced in cross-border transactions, securities law and corporate finance. Works with startups, entrepreneurs and global corporations in the technology, medical device and life science industries, among others.
Interviewees comment on the firm's "breadth of experience internationally in matters beyond just the corporate side."
One client says: "They are responsive, client-focused, and willing to bend over backwards to meet demanding timelines. The advice they give is both sound and practical."
Represented Iovance Biotherapeutics in its $603.7 million follow-on public offering.
Andrew Gilbert represents companies from a range of industries in business sales, acquisitions and other corporate and financing matters.
"He is very knowledgeable and can provide insight into the main issues of a deal and how to get them resolved." "He is practical and oriented toward getting transactions done." "An outstanding lawyer in all respects - I am continually amazed at his expertise."
Emilio Ragosa operates a respected practice in a number of hi-tech industries, involving the representation of companies in M&A, as well as IPOs and venture capital matters.
"He is able to see both sides of a transaction and find resolutions on issues to help to get deals accomplished."
Kevin Grant is recognized for his skill acting on M&A and private equity matters. He has notable experience in representing software companies, among other clients.
"He has good market knowledge and is totally focused on his clients' objectives." "Kevin is highly commercial and pragmatic - we consider him a business partner as he understands the context of what we are trying to achieve."
Scott Cowan concentrates his practice on M&A and securities matters, often involving companies in the technology industry.
"He is very constructive in his approach to deals and negotiations." "He has the ability to distill issues down to what we need to address and get to a result both clients can live with."